Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126125941 | 12612594 | 1 | I | 20160726 | 20160801 | 20160801 | EXP | US-ABBVIE-16P-163-1690328-00 | ABBVIE | LOCHHEAD J, NELSON M, SCHNEIDER A. RISKS AND BENEFITS OF RAPID CLOZAPINE TITRATION. MENTAL ILLNESS. 2016 JAN 01;8:14-15. | 21.00 | YR | M | Y | 0.00000 | 20160801 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126125941 | 12612594 | 1 | PS | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Unknown | UNKNOWN | 18723 | ||||||||||
| 126125941 | 12612594 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | UNKNOWN | 0 | 250 | MG | ||||||||
| 126125941 | 12612594 | 3 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | UNKNOWN | 0 | 175 | MG | ||||||||
| 126125941 | 12612594 | 4 | SS | CLOZAPINE. | CLOZAPINE | 1 | Unknown | UNKNOWN | 0 | 200 | MG | QD | |||||||
| 126125941 | 12612594 | 5 | SS | CHLORPROMAZINE. | CHLORPROMAZINE | 1 | Unknown | UNKNOWN | 0 | 200 | MG | QD | |||||||
| 126125941 | 12612594 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNKNOWN | 0 | 6 | MG | QD | |||||||
| 126125941 | 12612594 | 7 | SS | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Unknown | UNKNOWN | 0 | 50 | MG | QD | |||||||
| 126125941 | 12612594 | 8 | SS | LORAZEPAM. | LORAZEPAM | 1 | Unknown | UNKNOWN | 0 | 2 | MG | ||||||||
| 126125941 | 12612594 | 9 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Unknown | UNKNOWN | 0 | 10 | MG | QD | |||||||
| 126125941 | 12612594 | 10 | C | DULOXETINE. | DULOXETINE | 1 | 0 | ||||||||||||
| 126125941 | 12612594 | 11 | C | OXCARBAZEPINE. | OXCARBAZEPINE | 1 | 0 | ||||||||||||
| 126125941 | 12612594 | 12 | C | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126125941 | 12612594 | 1 | Product used for unknown indication |
| 126125941 | 12612594 | 2 | Schizophrenia |
| 126125941 | 12612594 | 5 | Product used for unknown indication |
| 126125941 | 12612594 | 6 | Product used for unknown indication |
| 126125941 | 12612594 | 7 | Aggression |
| 126125941 | 12612594 | 8 | Aggression |
| 126125941 | 12612594 | 9 | Aggression |
| 126125941 | 12612594 | 10 | Product used for unknown indication |
| 126125941 | 12612594 | 11 | Product used for unknown indication |
| 126125941 | 12612594 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126125941 | 12612594 | HO |
| 126125941 | 12612594 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126125941 | 12612594 | Blood creatine phosphokinase increased | |
| 126125941 | 12612594 | Disorientation | |
| 126125941 | 12612594 | Drug interaction | |
| 126125941 | 12612594 | Heart rate increased | |
| 126125941 | 12612594 | Lethargy | |
| 126125941 | 12612594 | Medication error | |
| 126125941 | 12612594 | Muscle rigidity | |
| 126125941 | 12612594 | Neuroleptic malignant syndrome | |
| 126125941 | 12612594 | Pyrexia | |
| 126125941 | 12612594 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126125941 | 12612594 | 1 | 20150106 | 0 | ||
| 126125941 | 12612594 | 2 | 20141230 | 0 | ||
| 126125941 | 12612594 | 3 | 20150106 | 0 |